Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 8: Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period

Click on country-registry for comparison

Flag	Country-registry	Registration period	Period approach, Calendar period						Cohort approach, Calendar period
Flag	Country-registry	Registration period	73-77	78-82(*)	83-87(*)	88-92(*)	93-97(*)	97-00	73-77	78-82(*)	83-87(*)	88-92(*)	93-97(*)	97-00
	China - Qidong	1992-2000		4.5	28.1	22.4	31.2	29.2		14.3	11.4	19.6	29.7	35.0
	Singapore	1993-1997	43.6	38.4	38.8	50.7	57.4		37.3	41.5	35.4	45.6	52.4

(*) Qidong calendar period did not match exactly with Singapore. Qidong interval are 77-81, 82-86, 87-91, 92-96, and 97-00.

Graphs:

Up-to-date 5-year relative survival estimates using period approach by site:
sort by country

Up-to-date 5-year relative survival estimates using cohort approach by site:
sort by country

Other tables available:

- Table 1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b:	Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6:	Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9:	Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period